Malaria Hybrids: A Chronological Evolution

Author(s): Akranth Marella*, Garima Verma, Md. Shaquiquzzaman, Md. Faraz Khan, Wasim Akhtar, Md. Mumtaz Alam*

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 19 , Issue 14 , 2019


Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

Malaria, an upsetting malaise caused by a diverse class of Plasmodium species affects about 40% of the world’s population. The distress associated with it has reached colossal scales owing to the development of resistance to most of the clinically available agents. Hence, the search for newer molecules for malaria treatment and cure is an incessant process. After the era of a single molecule for malaria treatment ended, there was an advent of combination therapy. However, lately there had been reports of the development of resistance to many of these agents as well. Subsequently, at present most of the peer groups working on malaria treatment aim to develop novel molecules, which may act on more than one biological processes of the parasite life cycle, and these scaffolds have been aptly termed as Hybrid Molecules or Double Drugs. These molecules may hold the key to hitherto unknown ways of showing a detrimental effect on the parasite. This review enlists a few of the recent advances made in malaria treatment by these hybrid molecules in a sequential manner.

Keywords: Combination therapy, double drugs, hybrid molecules, malaria, Plasmodium, chronological evaluation.

[1]
World Malaria Report, 2016 published by World Health Organisation.
[2]
Marella, A.; Verma, G.; Shaquiquzzaman, M.; Akhter, M.; Alam, M.M. Malaria: Hitches and Hopes. Mini Rev. Med. Chem., 2014, 14, 453-470.
[3]
Vangapandu, S.; Sachdeva, S.; Jain, M.; Singh, S.; Singh, P.P.; Kaul, C.L.; Jain, R. 8-quinolinamines and their pro prodrug conjugates as potent blood-schizontocidal antimalarial agents. Bioorg. Med. Chem., 2003, 11, 4557-4568.
[4]
Capela, R.; Oliveira, R.; Goncalves, L.M.; Domingos, A.; Gut, J.; Rosenthal, P.J.; Lopes, F.; Moreira, R. Artemisinin-dipeptidylvinyl sulfone hybrid molecules: Design, synthesis and preliminary SAR for antiplasmodial activity and falcipain-2 inhibition. Bioorg. Med. Chem. Lett., 2009, 19, 3229-3232.
[5]
Araujo, N.C.; Barton, V.; Jones, M.; Stocks, P.A.; Ward, S.A.; Davies, J.; Bray, P.G.; Shone, A.E.; Cristiano, M.L.; O’Neill, P.M. Semisynthetic and synthetic 1,2,4-trioxaquines and 1,2,4-trioxolaquines: Synthesis, preliminary SAR and comparison with acridine endoperoxide conjugates. Bioorg. Med. Chem. Lett., 2009, 19, 2038-2043.
[6]
Noedl, H.; Se, Y.; Schaecher, K.; Smith, B.L.; Socheat, D.; Fukuda, M.M. Evidence of artemisinin-resistant malaria in western Cambodia. N. Engl. J. Med., 2008, 359, 2619-2620.
[7]
Cabaret, O.D.; Vical, F.B.; Robert, A.; Meunier, B. Preparation and antimalarial activities of “Trioxaquines”, new modular molecules with a trioxane skeleton linked to a 4-aminoquinoline. ChemBioChem, 2000, 1, 281-283.
[8]
Chauhan, S.S.; Sharma, M.; Chauhan, P.M.S. Trioxaquines: Hybrid molecules for the treatment of malaria. Drug News Perspect., 2010, 23, 632-646.
[9]
Biot, C. Ferroquine: A new weapon in the fight against malaria. Curr. Med. Chem. Antiinfect. Agents, 2004, 3, 135-147.
[10]
Bellot, F.; Cosledan, F.; Vendier, L.; Brocard, J.; Meunier, B.; Robert, A. Trioxaferroquines as new hybrid antimalarial drugs. J. Med. Chem., 2010, 53, 4103-4109.
[11]
Oliveira, R.; Miranda, D.; Magalhaes, J.; Capela, R.; Perry, M.J.; O’Neill, P.M.; Moreira, R.; Lopes, F. From hybrid compounds to targeted drug delivery in antimalarial therapy. Bioorg. Med. Chem., 2015, 23, 5120-5130.
[12]
Arnaud, C.H. Drug hybrids enter the fray. Sci. Technol., 2007, 85, 46-48.
[13]
Meunier, B. Hybrid molecules with a dual mode of action: Dream or Reality? Acc. Chem. Res., 2008, 41, 69-77.
[14]
Cabaret, O.D.; Vical, F.B.; Robert, A.; Meunier, B. Preparation and antimalarial activities of “Trioxaquines”, new modular molecules with a trioxane skeleton linked to a 4-Aminoquinoline. ChemBioChem, 2000, 17, 281-283.
[15]
Cabaret, O.D.; Vical, F.B.; Loup, C.; Robert, A.; Gornitzka, H.; Bonhoure, A.; Vial, H.; Magnaval, J.F.; Seguela, J.P.; Meunier, B. Synthesis and antimalarial activity of trioxaquine derivatives. Chem. Eur. J, 2004, 10, 1625-1636.
[16]
Singh, C.; Malik, H.; Puri, S.K. Synthesis and antimalarial activity of a new series of trioxaquines. Bioorg. Med. Chem., 2004, 12, 1177-1182.
[17]
Agarwal, A.; Srivastava, K.; Puri, S.K.; Chauhan, P.M.S. Syntheses of 2,4,6-trisubstituted triazines as antimalarial agents. Bioorg. Med. Chem. Lett., 2005, 15, 531-533.
[18]
Chiyanzu, I.; Clarkson, C.; Smith, P.J.; Lehman, J.; Gut, J.; Rosenthal, P.J.; Chibale, K. Design, synthesis and anti-plasmodial evaluation in vitro of new 4-aminoquinoline isatin derivatives. Bioorg. Med. Chem., 2005, 13, 3249-3261.
[19]
Katiyar, S.B.; Srivastava, K.; Puri, S.K.; Chauhan, P.M.S. Synthesis of 2- [3,5-substituted pyrazol-1-yl]-4,6-trisubstituted triazine derivatives as antimalarial agents. Bioorg. Med. Chem. Lett., 2005, 15, 4957-4960.
[20]
Burgess, S.J.; Selzer, A.; Kelly, J.X.; Smilkstein, M.J.; Riscoe, M.K.; Peyton, D.H. A chloroquine-like molecule designed to reverse resistance in Plasmodium falciparum. J. Med. Chem., 2006, 49, 5623-5625.
[21]
Biot, C.; Daher, W.; Ndiaye, C.M.; Melnyk, P.; Pradines, B.; Chavain, N.; Pellet, A. Fraisse. L.; Pelinski, L.; Jarry, C.; Brocard. J.; Khalife, J.; Bares, I.F.; Dive D. Probing the role of the covalent linkage of ferrocene into a chloroquine template. J. Med. Chem., 2006, 49, 4707-4714.
[22]
Walsh, J.J.; Coughlan, D.; Heneghan, N.; Gaynor, C.; Bell, A. A novel artemisinin-quinine hybrid with potent antimalarial activity. Bioorg. Med. Chem. Lett., 2007, 17, 3599-3602.
[23]
Vical, F.B.; Lelievre, J.; Berry, A.; Deymier, C.; Cabaret, O.D.; Cazelles, J.; Loup, C.; Robert, A.; Magnaval, J.F.; Meunier, B. Trioxaquines are new antimalarial agents active on all erythrocytic forms, including gametocytes. Antimicrob. Agents Chemother., 2007, 51, 1463-1472.
[24]
Kumar, A.; Srivastava, K.; Kumar, S.R.; Puri, S.K.; P.M.S., Chauhan Synthesis and bioevaluation of hybrid 4-aminoquinoline triazines as a new class of antimalarial agents. Bioorg. Med. Chem. Lett., 2008, 18, 6530-6533.
[25]
Melato, S.; Prosperi, D.; Coghi, P.; Basilico, N.; Monti, D. A combinatorial approach to 2,4,6-trisubstituted triazines with potent antimalarial activity: Combining conventional synthesis and microwave-assistance. ChemMedChem, 2008, 3, 873-876.
[26]
Mishra, S.; Karmodiya, K.; Parasuraman, P.; Surolia, A.; Surolia, N. Design, synthesis, and application of novel triclosan prodrugs as potential antimalarial and antibacterial agents. Bioorg. Med. Chem., 2008, 16, 5536-5546.
[27]
Varotti, F. de P, Botelho, A.C.C.; Andrade, A.A.; de Paula, R.C.; Fagundes, E.M.S.; Valverde, A.; Mayer, L.M.U.; Mendonca, J.S.; de Souza, M.V.N.; Boechat, N.; Krettli, A.U. Synthesis, antimalarial activity, and intracellular targets of MEFAS, a new hybrid compound derived from Mefloquine and Artesunate. Antimicrob. Agents Chemother., 2008, 52, 3868-3874.
[28]
Friebolin, W.; Jannack, B.; Wenzel, N.; Furrer, J.; Oeser, T.; Sanchez, C.P.; Lanzer, M.; Yardley, V.; Becker, K.; Charvet, E.D. Antimalarial dual drugs based on potent inhibitors of glutathione reductase from Plasmodium falciparum. J. Med. Chem., 2008, 51, 1260-1277.
[29]
Gupta, L.; Srivastava, K.; Singh, S.; Puri, S.K. Chauhan. P.M.S. Synthesis of 2-[3-(7-Chloro-quinolin-4-ylamino)-alkyl]-1-(substituted phenyl)-2,3,4,9-tetrahydro-1H-β-carbolines as a new class of antimalarial agents. Bioorg. Med. Chem. Lett., 2008, 18, 3306-3309.
[30]
Acharya, B.N.; Thavaselvam, D.; Kaushik, M.P. Synthesis and antimalarial evaluation of novel pyridine quinoline hybrids. Med. Chem. Res., 2008, 17, 487-494.
[31]
Kumar, A.; Srivastava, K.; Kumar, S.R.; Puri, S.K.; Chauhan, P.M.S. Synthesis of 9-anilinoacridine triazines as new class of hybrid antimalarial agents. Bioorg. Med. Chem. Lett., 2009, 19, 6996-6999.
[32]
Sunduru, N.; Sharma, M.; Srivastava, K.; Rajakumar, S.; Puri, S.K.; Saxena, J.K.; Chauhan, P.M.S. Synthesis of oxalamide and triazine derivatives as a novel class of hybrid 4-aminoquinoline with potent antiplasmodial activity. Bioorg. Med. Chem., 2009, 17, 6451-6462.
[33]
Gemma, S.; Campiani, G.; Butini, S.; Joshi, B.P.; Kukreja, G.; Coccone, S.S.; Bernetti, M.; Persico, M.; Nacci, V.; Fiorini, I.; Novellino, E.; Taramelli, D.; Basilico, N.; Parapini, S.; Yardley, V.; Croft, S.; Maerki, S.K.; Rottmann, M.; Brun, R.; Coletta, M.; Marini, S.; Guiso, G.; Caccia, S.; Fattorusso, C. Combining 4-aminoquinoline- and clotrimazole based pharmacophores toward innovative and potent hybrid antimalarials. J. Med. Chem., 2009, 52, 502-513.
[34]
Jones, M.; Mercer, A.E.; Stocks, P.A.; Pensee, L.J.I.L.; Cosstick, R.; Park, B.K.; Kennedy, M.E.; Piantanida, I.; Ward, S.A.; Davies, J.; Bray, P.G.; Rawe, S.L.; Baird, J.; Charidza, T.; Janneh, O.; o’Neill, P.M. Antitumour and antimalarial activity of artemisinin-acridine hybrids. Bioorg. Med. Chem. Lett., 2009, 19, 2033-2037.
[35]
Musonda, C.C.; Whitlock, G.A.; Witty, M.J.; Brun, R.; Kaiser, M. Chloroquine-astemizole hybrids with potent in vitro and in vivo antiplasmodial activity. Bioorg. Med. Chem. Lett., 2009, 19, 481-484.
[36]
Lombard, M.C.; N’Da, D.D.; Breytenbach, J.C.; Smith, P.J.; Lategan, C.A. Artemisinin-quinoline hybrid-dimers: Synthesis and in vitro antiplasmodial activity. Bioorg. Med. Chem. Lett., 2010, 20, 6975-6977.
[37]
Lombard, M.C.; N’Da, D.D.; Breytenbach, J.C.; Kolesnikova, N.I.; Ba, C.T.V.; Wein, S.; Norman, J.; Denti, P.; Vial, H.; Wiesner, L. Antimalarial and anticancer activities of artemisinin-quinoline hybrid- dimers and pharmacokinetic properties in mice. Eur. J. Pharm. Sci., 2012, 47, 834-841.
[38]
Guantai, E.M.; Ncokazi, K.; Egan, T.J.; Gut, J.; Rosenthal, P.J.; Smith, P.J. Chibale. K. Design, synthesis and in vitro antimalarial evaluation of triazole-linked chalcone and dienone hybrid compounds. Bioorg. Med. Chem., 2010, 18, 8243-8256.
[39]
Kumar, A.; Srivastava, K.; Kumar, S.R.; Puri, S.K.; Chauhan, P.M.S. Synthesis of new 4-aminoquinolines and quinoline-acridine hybrids as antimalarial agents. Bioorg. Med. Chem. Lett., 2010, 20, 7059-7063.
[40]
Bellot, F.; Cosledan, F.; Vendier, L.; Brocard, J.; Meunier, B.; Robert, A. Trioxaferroquines as new hybrid antimalarial drugs. J. Med. Chem., 2010, 53, 4103-4109.
[41]
Bhat, H.R.; Singh, U.P.; Yadav, P.S.; Kumar, V.; Gahtori, P.; Das, A.; Chetia, D.; Prakash, A.; Mahanta, J. Synthesis, characterization and antimalarial activity of hybrid 4-aminoquinoline-1,3,5-triazine derivatives. Arab. J. Chem., 2011, 9, S625-S631.
[42]
Bertinaria, M.; Guglielmo, S.; Rolando, B.; Giorgis, M.; Aragno, C.; Fruttero, R.; Gasco, A.; Parapini, S.; Taramelli, D.; Martins, Y.C.; Carvalho, L.J.M. Amodiaquine analogues containing NO-donor substructures: Synthesis and their preliminary evaluation as potential tools in the treatment of cerebral malaria. Eur. J. Med. Chem., 2011, 46, 1757-1767.
[43]
Lombard, M.C.; N’Da, D.D.; Breytenbach, J.C.; Smith, P.J.; Lategan, C.A. Synthesis, in vitro antimalarial and cytotoxicity of artemisinin-aminoquinoline hybrids. Bioorg. Med. Chem. Lett., 2011, 21, 1683-1686.
[44]
Ruiz, F.A.R.; Sanchez, R.N.G.; Estupinan, S.V.; Barrio, A.G.; Amado, D.F.T.; Solorzano, B.M.P.; Ruiz, J.J.N.; Fernandez, A.R.M.; Kouznetsov, V.V. Synthesis and antimalarial activity of new heterocyclic hybrids based on chloroquine and thiazolidinone scaffolds. Bioorg. Med. Chem., 2011, 19, 4562-4573.
[45]
Kumar, A.; Srivastava, K.; Kumar, S.R.; Siddiqi, M.I.; Puri, S.K.; Sexana, J.K.; Chauhan, P.M.S. 4-Anilinoquinoline triazines: A novel class of hybrid antimalarial agents. Eur. J. Med. Chem., 2011, 46, 676-690.
[46]
Hans, R.H.; Wiid, I.J.F.; van Helden, P.D.; Wan, B.; Franzblau, S.G.; Gut, J.; Rosenthal, P.J.; Chibale, K. Novel thiolactone-isatin hybrids as potential antimalarial and antitubercular agents. Bioorg. Med. Chem. Lett., 2011, 21, 2055-2058.
[47]
Chadwick, J.; Amewu, R.K.; Marti, F.; Garah, F.B.E.; Sharma, R.; Berry, N.G.; Stocks, P.A.; Saward, H.B.; Wittlin, S.; Rottmann, M.; Brun, R.; Taramelli, D.; Parapini, S.; Ward, S.A.; O’Neill, P.M. Antimalarial mannoxanes: Hybrid antimalarial drugs with outstanding oral activity profiles and a potential dual mechanism of action. ChemMedChem, 2011, 6, 1357-1361.
[48]
Quirante, J.; Dubar, F.; Gonzalez, A.; Lopez, C.; Cascante, M.; Cortes, R.; Forfar, I.; Pradines, B.; Biot, C. Ferrocene-indole hybrids for cancer and malaria therapy. J. Organomet. Chem., 2011, 696, 1011-1017.
[49]
Gemma, S.; Camodeca, C.; Coccone, S.S.; Joshi, B.P.; Bernetti, M.; Moretti, V.; Brogi, S.; Bonache, M.C.; Savini, L.; Taramelli, D.; Basilico, N.; Parapini, S.; Rottmann, M.; Brun, R.; Lamponi, S.; Caccia, S.; Guiso, G.; Summer, R.; Martin, R.; Saponara, S.; Gorelli, B.; Novellino, E.; Campiani, G.; Butini, S. Optimization of 4-aminoquinoline/clotrimazole-based hybrid antimalarials: Further structure activity relationships, in vivo studies, and preliminary toxicity profiling. J. Med. Chem., 2012, 55, 6948-6967.
[50]
Manohar, S.; Rajesh, U.C.; Khan, S.I.; Tekwani, B.L.; Rawat, D.S. Novel 4-aminoquinoline-pyrimidine based hybrids with improved in vitro and in vivo antimalarial activity. Med. Chem. Lett., 2012, 3, 555-559.
[51]
Starcevi, K.; Pesic, D.; Toplak, A.; Landek, G.; Alihodzic, S.; Herreros, E.; Ferrer, S.; Spaventi, R.; Peric, M. Novel hybrid molecules based on 15-membered azalide as potential antimalarial agents. Eur. J. Med. Chem., 2012, 49, 365-378.
[52]
Singh, P.; Singh, P.; Kumar, M.; Gut, J.; Rosenthal, P.J.; Kumar, K.; Kumar, V.; Mahajan, M.P.; Bisetty, K. Synthesis, docking and in vitro antimalarial evaluation of bifunctional hybrids derived from β-lactams and 7-chloroquinoline using click chemistry. Bioorg. Med. Chem. Lett., 2012, 22, 57-61.
[53]
Sashidhara, K.V.; Kumar, M.; Modukuri, R.K.; Srivastava, R.K.; Soni, A.; Srivastava, K.; Singh, S.V.; Saxena, J.K.; Gauniyal, H.M.; Puri, S.K. Antiplasmodial activity of novel keto-enamine chalcone-chloroquine based hybrid pharmacophores. Bioorg. Med. Chem., 2012, 20, 2971-2981.
[54]
Sharma, N.; Mohanakrishnan, D.; Shard, A.; Sharma, A. Saima, Sinha, A.K.; Sahal, D. Stilbene-Chalcone hybrids: Design, synthesis, and evaluation as a new class of antimalarial scaffolds that trigger cell death through stage specific apoptosis. J. Med. Chem., 2012, 55, 297-311.
[55]
Sashidhara, K.V.; Avula, S.R.; Palnati, G.R.; Singh, S.V.; Srivastava, K.; Puri, S.K.; Saxena, J.K. Synthesis and in vitro evaluation of new chloroquine-chalcone hybrids against chloroquine-resistant strain of Plasmodium falciparum. Bioorg. Med. Chem. Lett., 2012, 22, 5455-5459.
[56]
Sashidhara, K.V.; Kumar, A.; Dodda, R.P.; Krishna, N.N.; Agarwal, P.; Srivastava, K.; Puri, S.K. Coumarin-trioxane hybrids: Synthesis and evaluation as a new class of antimalarial scaffolds. Bioorg. Med. Chem. Lett., 2012, 22, 3926-3930.
[57]
Gahtori, P.; Ghosh, S.K.; Parida, P.; Prakash, A.; Gogoi, K.; Bhat, H.R.; Singh, U.P. Antimalarial evaluation and docking studies of hybrid phenylthiazolyl-1,3,5-triazine derivatives: A novel and potential antifolate lead for Pf-DHFR-TS inhibition. Exp. Parasitol., 2012, 130, 292-299.
[58]
Singh, K.; Kaur, H.; Chibale, K.; Balzarini, J.; Little, S.; Bharatam, P.V. 2-Aminopyrimidine based 4-aminoquinoline anti-plasmodial agents. Synthesis, biological activity, structure-activity relationship and mode of action studies. Eur. J. Med. Chem., 2012, 52, 82-97.
[59]
Perez, B.C.; Teixeira, C.; Figueiras, M.; Gut, J.; Rosenthal, P.J.; Gomes, J.R.B.; Gomes, P. Novel cinnamic acid/4-aminoquinoline conjugates bearing non-proteinogenic amino acids: Towards the development of potential dual action antimalarials. Eur. J. Med. Chem., 2012, 54, 887-899.
[60]
Boechat, N.; Pinheiro, L.C.S.; Silva, T.S.; Aguiar, A.C.C.; Carvalho, A.S.; Bastos, M.M.; Costa, C.C.P.; Pinheiro, S.; Pinto, A.C.; Mendonca, J.S.; Dutra, K.D.B.; Valverde, A.L.; Filho, O.A.S.; Ceravolo, I.P.; Krettli, A.U. New trifluoromethyl triazolopyrimidines as anti-Plasmodium falciparum agents. Molecules, 2012, 17, 8285-8302.
[61]
Singh, K.; Kaur, H.; Chibale, K.; Balzarini, J. Synthesis of 4-aminoquinoline-pyrimidine hybrids as potent antimalarials and their mode of action studies. Eur. J. Med. Chem., 2013, 66, 314-323.
[62]
Andayi, W.A.; Egan, T.J.; Gut, J.; Rosenthal, P.J.; Chibale, K. Synthesis, antiplasmodial activity, and β- hematin inhibition of hydroxypyridone- chloroquine hybrids. ACS Med. Chem. Lett., 2013, 4, 642-646.
[63]
Njogu, P.M.; Gut, J.; Rosenthal, P.J.; Chibale, K. Design, synthesis, and antiplasmodial activity of hybrid compounds based on (2R,3S)-N-Benzoyl-3-phenylisoserine. ACS Med. Chem. Lett., 2013, 4, 637-641.
[64]
Perez, B.C.; Teixeira, C.; Albuquerque, I.S.; Gut, J.; Rosenthal, P.J.; Gomes, J.R.B.; Prudencio, M.; Gomes, P. N-cinnamoylated chloroquine analogues as dual-stage antimalarial leads. J. Med. Chem., 2013, 56, 556-567.
[65]
Lodige, M.; Lewis, M.D.; Paulsen, E.S.; Esch, H.L.; Pradel, G.; Lehmann, L.; Brun, R.; Bringmann, G.; Mueller, A.K. A primaquine-chloroquine hybrid with dual activity against Plasmodium liver and blood stages. Int. J. Med. Microbiol., 2013, 303, 539-547.
[66]
Pretorius, S.I.; Breytenbach, W.J.; de Kock, C.; Smith, P.J.; N’Da, D.D. Synthesis, characterization and antimalarial activity of quinoline-pyrimidine hybrids. Bioorg. Med. Chem., 2013, 21, 269-277.
[67]
Oliveira, R.; Newton, A.S.; Guedes, R.C.; Miranda, D.; Amewu, R.K.; Srivastava, A.; Gut, J.; Rosenthal, P.J.; O’Neill, P.M.; Ward, S.A.; Lopes, F.; Moreira, R. An endoperoxide-based hybrid approach to deliver falcipain inhibitors inside malaria parasites. ChemMedChem, 2013, 8, 1528-1536.
[68]
Singh, K.; Kaur, H.; Smith, P.; de Kock, C.; Chibale, K.; Balzarini, J. Quinoline-pyrimidine hybrids: Synthesis, antiplasmodial activity, SAR, and mode of action studies. J. Med. Chem., 2014, 57, 435-448.
[69]
Smit, F.J.; N’Da, D.D. Synthesis, in vitro antimalarial activity and cytotoxicity of novel 4-aminoquinolinyl-chalcone amides. Bioorg. Med. Chem., 2014, 22, 1128-1138.
[70]
Joubert, J.P.; Smit, F.J.; du Plessis, L.; Smith, P.J.; N’Da, D.D. Synthesis and in vitro biological evaluation of aminoacridines and artemisinin-acridine hybrids. Eur. J. Pharm. Sci., 2014, 56, 16-27.
[71]
Cloete, T.T.; de Kock, C.; Smith, P.J.; N’Da, D.D. Synthesis, in vitro antiplasmodial activity and cytotoxicity of a series of artemisinine-triazine hybrids and hybrid-dimers. Eur. J. Med. Chem., 2014, 76, 470-481.
[72]
Wang, N.; Wicht, K.J.; Shaban, E.; Ngoc, T.A.; Wang, M.Q.; Hayashi, I.; Hossain, M.I.; Takemasa, Y.; Kaiser, M.; Sayed, I.E.T.E.; Egan, T.J.; Inokuchi, T. Synthesis and evaluation of artesunate-indoloquinoline hybrids as antimalarial drug candidates. MedChemComm, 2014, 5, 927-931.
[73]
Mishra, A.; Batchu, H.; Srivastava, K.; Singh, P.; Shukla, P.K.; Batra, S. Synthesis and evaluation of new diaryl ether and quinoline hybrids as potential antiplasmodial and antimicrobial agents. Bioorg. Med. Chem. Lett., 2014, 24, 1719-1723.
[74]
Andayi, W.A.; Egan, T.J.; Chibale, K. Kojic acid derived hydroxypyridinone-chloroquine hybrids: Synthesis, crystal structure, antiplasmodial activity and β-haematin inhibition. Bioorg. Med. Chem. Lett., 2014, 24, 3263-3267.
[75]
Oliveira, R.; Guedes, R.C.; Meireles, P.; Albuquerque, I.S.; Goncalves, L.M.; Pires, E.; Bronze, M.R.; Gut, J.; Rosenthal, P.J.; Prudencio, M.; Moreira, R.; O’Neill, P.M.; Lopes, F. Tetraoxane-pyrimidine nitrile hybrids as dual stage antimalarials. J. Med. Chem., 2014, 57, 4916-4923.
[76]
Reiter, C.; Karagoz, A.C.; Frohlich, T.; Klein, V.; Zeino, M.; Viertel, K.; Held, J.; Mordmuller, B.; Ozturk, S.E.; Anil, H.; Efferth, T.; Tsogoeva, S.B. Synthesis and study of cytotoxic activity of 1,2,4-trioxane- and egonol-derived hybrid molecules against Plasmodium falciparum and multidrug-resistant human leukemia cells. Eur. J. Med. Chem., 2014, 75, 403-412.
[77]
Boechat, N.; Ferreira, M.D.L.G.; Pinheiro, L.C.S.; Jesus, A.M.L.; Leite, M.M.M.; Junior, C.C.S.; Aguiar, A.C.C.; de Andrade, I.M.; Krettli, A.U. New compounds hybrids 1H-1,2,3-triazole-quinoline against Plasmodium falciparum. Chem. Biol. Drug Des., 2014, 84, 325-332.
[78]
Marella, A.; Akhter, M.; Shaquiquzzaman, M.; Husain, A.; Akhter, W.; Verma, G.; Alam, M.M. Synthesis and in-vitro antimalarial evaluation of Pyrazoline: A new antimalarial Scaffold. J. Pharm. Res., 2014, 8, 77-80.
[79]
Murugan, K.; Raichurkar, A.V.; Khan, F.R.N. Iyer. P.S. Synthesis and in vitro evaluation of novel 8-aminoquinoline-pyrazolopyrimidine hybrids as potent antimalarial agents. Bioorg. Med. Chem. Lett., 2015, 25, 1100-1103.
[80]
Kumar, D.; Khan, S.I.; Tekwani, B.L.; Ponnan, P.; Rawat, D.S. 4-Aminoquinoline-Pyrimidine hybrids: Synthesis, antimalarial activity, heme binding and docking studies. Eur. J. Med. Chem., 2015, 89, 490-502.
[81]
Bhat, H.R.; Singh, U.P.; Thakur, A.; Ghosh, S.K.; Gogoi, K.; Prakash, A.; Singh, R.K. Synthesis, antimalarial activity and molecular docking of hybrid 4-aminoquinoline-1,3,5-triazine derivatives. Exp. Parasitol., 2015, 157, 59-67.
[82]
Raj, R.; Saini, A.; Gut, J.; Rosenthal, P.J.; Kumar, V. Synthesis and in vitro antiplasmodial evaluation of 7-chloroquinoline-chalcone and 7-chloroquinoline-ferrocenylchalcone conjugates. Eur. J. Med. Chem., 2015, 95, 230-239.
[83]
Bertinaria, M.; Sanchez, P.O.; Marini, E.; Guglielmo, S.; Hofer, A.; Martins, Y.C.; Zanini, G.M.; Frangos, J.A.; Gasco, A.; Fruttero, R.; Carvalho, L.J.M. NO-donor dihydroartemisinin derivatives as multitarget agents for the treatment of cerebral malaria. J. Med. Chem., 2015, 58, 7895-7899.
[84]
Lodige, M.; Hiersch, L. Design and synthesis of novel hybrid molecules against malaria. Int. J. Med. Chem., 2015, 2015, 1-23.
[85]
Kaur, H.; Machado, M.; de Kock, C.; Smith, P.; Chibale, K.; Prudencio, M.; Singh, K. Primaquine-pyrimidine hybrids: Synthesis and dual-stage antiplasmodial activity. Eur. J. Med. Chem., 2015, 101, 266-273.
[86]
Bekhit, A.A.; Hassan, A.M.; El-Razik, H.A.A.; El-Miligy, M.M.M.; El-Agroudy, E.J.; Bekhit, A.E.D.A. New heterocyclic hybrids of pyrazole and its bioisosteres: Design, synthesis and biological evaluation as dual acting antimalarial-antileishmanial agents. Eur. J. Med. Chem., 2015, 94, 30-44.
[87]
Kaur, H.; Balzarini, J.; de Kock, C.; Smith, P.J.; Chibale, K.; Singh, K. Synthesis, antiplasmodial activity and mechanistic studies of pyrimidine-5-carbonitrile and quinoline hybrids. Eur. J. Med. Chem., 2015, 101, 52-62.
[88]
Pinheiro, L.C.S.; Boechat, N.; Ferreira, M.D.L.G.; Junior, C.C.S.; Jesus, A.M.L.; Leite, M.M.M.; Souza, N.B.; Krettli, A.U. Anti-Plasmodium falciparum activity of quinoline-sulfonamide hybrids. Bioorg. Med. Chem., 2015, 23, 5979-5984.
[89]
Reiter, C.; Frohlich, T.; Zeino, M.; Marschall, M.; Bahsi, H.; Leidenberger, M.; Friedrich, O.; Kappes, B.; Hampel, F.; Efferth, T.; Tsogoeva, S.B. New efficient artemisinin derived agents against human leukemia cells, human cytomegalovirus and Plasmodium falciparum: 2nd generation 1,2,4-trioxane-ferrocene hybrids. Eur. J. Med. Chem., 2015, 97, 164-172.
[90]
Marella, A.; Akhter, M.; Shaquiquzzaman, M.; Tanwar, O.; Verma, G.; Alam, M.M. Synthesis, 3D-QSAR and docking studies of pyrimidine nitrile-pyrazoline: A novel class of hybrid antimalarial agents. Med. Chem. Res., 2015, 24, 1018-1037.
[91]
Marella, A.; Shaquiquzzaman, M.; Akhter, M.; Verma, G.; Alam, M.M. Novel pyrazole-pyrazoline hybrids endowed with thioamide as antimalarial agents: Their synthesis and 3D-QSAR studies. J. Enzyme Inhib. Med. Chem., 2015, 30, 597-606.
[92]
Dana, S.; Keshri, S.K.; Shukla, J.; Vikramdeo, K.S.; Mondal, N.; Mukhopadhyay, P.; Dhar, S.K. Design, synthesis and evaluation of bifunctional acridinine-naphthalenediimide redox-active conjugates as antimalarials. ACS Omega, 2016, 1, 318-333.
[93]
Sahu, S.; Ghosh, S.K.; Kalita, J.; Dutta, M.; Bhat, H.R. Design, synthesis and antimalarial screening of some hybrid 4-aminoquinoline-triazine derivatives against pf-DHFR-TS. Exp. Parasitol., 2016, 163, 38-45.
[94]
Pandey, A.K.; Sharma, S.; Pandey, M.; Alam, M.M.; Shaquiquzzaman, M.; Akhter, M. 4,5-Dihydrooxazole-pyrazoline hybrids: Synthesis and their evaluation as potential antimalarial agents. Eur. J. Med. Chem., 2016, 123, 476-486.
[95]
Silva, T.B.; Bernardino, A.M.R.; Ferreira, M.D.L.G.; Rogerio, K.R.; Carvalho, L.J.M.; Boechat, N.; Pinheiro, L.C.S. Design, synthesis and anti-P. falciparum activity of pyrazolopyridine-sulfonamide derivatives. Bioorg. Med. Chem., 2016, 24, 4492-4498.
[96]
Carvalho, R.C.C.; Martins, W.A.; Silva, T.P.; Kaiser, C.R.; Bastos, M.M.; Pinheiro, L.C.S.; Krettli, A.U.; Boechat, N. New pentasubstituted pyrrole hybrid atorvastatin-quinoline derivatives with antiplasmodial activity. Bioorg. Med. Chem. Lett., 2016, 26, 1881-1884.
[97]
Reddy, P.L.; Khan, S.I.; Ponnan, P.; Tripathi, M.; Rawat, D.S. Design, synthesis and evaluation of 4-Aminoquinoline-purine hybrids as potential antiplasmodial agents. Eur. J. Med. Chem., 2017, 126, 675-686.
[98]
Kholiya, R.; Khan, S.I.; Bahuguna, A.; Tripathi, M.; Rawat, D.S. N-piperonyl substitution on aminoquinoline-pyrimidine hybrids: Effect on the antiplasmodial potency. Eur. J. Med. Chem., 2017, 131, 126-140.
[99]
Maurya, S.S.; Khan, S.I.; Bahuguna, A.; Kumar, D.; Rawat, D.S. Synthesis, antimalarial activity, heme binding and docking studies of N-substituted 4- aminoquinoline-pyrimidine molecular hybrids. Eur. J. Med. Chem., 2017, 129, 175-185.
[100]
Azeredo, L.F.S.P.; Coutinho, J.P.; Jabor, V.A.P.; Feliciano, P.R.; Nonato, M.C.; Kaiser, C.R.; Menezes, C.M.S.; Hammes, A.S.O.; Caffarena, E.R.; Hoelz, L.V.B.; de Souza, N.B.; Pereira, G.A.N.; Ceravolo, I.P.; Krettli, A.U.; Boechat, N. Evaluation of 7-arylaminopyrazolo[1,5-a] pyrimidines as anti-Plasmodium falciparum, antimalarial, and Pf-dihydroorotate dehydrogenase inhibitors. Eur. J. Med. Chem., 2017, 126, 72-83.
[101]
Pearce, A.N.; Kaiser, M.; Copp, B.R. Synthesis and antimalarial evaluation of artesunate-polyamine and trioxolanepolyamine conjugates. Eur. J. Med. Chem., 2017, 140, 595-603.
[102]
Kumar, S.; Saini, A.; Gut, J.; Rosenthal, P.J.; Raj, R.; Kumar, V. 4-Aminoquinoline-chalcone/-N-acetylpyrazoline conjugates: Synthesis and antiplasmodial evaluation. Eur. J. Med. Chem., 2017, 138, 993-1001.
[103]
Gayam, V.; Ravi, S. Cinnamoylated chloroquine analogues: A new structural class of antimalarial agents. Eur. J. Med. Chem., 2017, 135, 382-391.
[104]
Devender, N.; Gunjan, S.; Tripathi, R.; Tripathi, R.T. Synthesis and antiplasmodial activity of novel indoleamide derivatives bearing sulfonamide and triazole pharmacophores. Eur. J. Med. Chem., 2017, 131, 171-184.
[105]
Saikrishna, B.; Kumari, M.K.; Vijjulatha, M.; Allanki, A.D.; Prasad, R.; Sijwali, P.S. Synthesis and evaluation of Naphthyl bearing 1,2,3-Triazole analogs as antiplasmodial agents, cytotoxicity and docking studies. Bioorg. Med. Chem., 2017, 25, 221-232.
[106]
Mishra, V.K.; Mishra, M.; Kashaw, V.; Kashaw, S.K. Synthesis of 1,3,5-trisubstituted pyrazolines as potential antimalarial and antimicrobial agents. Bioorg. Med. Chem., 2017, 25, 1949-1962.
[107]
Patel, T.S.; Vanparia, S.F.; Patel, U.H.; Dixit, R.B.; Chudasama, C.J.; Patel, B.D.; Dixit, B.C. Novel 2,3-disubstituted quinazoline-4(3H)-one molecules derived from amino acid linked sulphonamide as a potent malarial antifolates for DHFR inhibition. Eur. J. Med. Chem., 2017, 129, 251-265.
[108]
Yadav, N.; Agarwal, D.; Kumar, S.; Dixit, A.K.; Gupta, A.D.; Awasthi, S.K. In vitro antiplasmodial efficacy of synthetic coumarin-triazole analogs. Eur. J. Med. Chem., 2018, 145, 735-745.
[109]
Chopra, R.; Chibale, K.; Singh, K. Pyrimidine-chloroquinoline hybrids: Synthesis and antiplasmodial activity. Eur. J. Med. Chem., 2018, 148, 39-53.
[110]
Capela, R.; Magalhaes, J.; Miranda, D.; Machado, M.; Vaz, M.S.; Albuquerque, I.S.; Sharma, M.; Gut, J.; Rosenthal, P.J.; Frade, R.; Perry, M.J. Eur. J. Med. Chem., 2018, 149, 69-78.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 19
ISSUE: 14
Year: 2019
Published on: 20 August, 2019
Page: [1144 - 1177]
Pages: 34
DOI: 10.2174/1389557519666190315100027
Price: $65

Article Metrics

PDF: 37
HTML: 6